Healthcare · Biotechnology · Market cap $366M · $4.28 · 52-week range $2.71–$6.42
Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.
| Date | Insider | Role | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-07-06 | Hamilton Thomas Edward | director | 50,000 | $3.34 | $166,890 | SEC Form 4 |
| 2026-02-27 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | 1,084,012 | $5.00 | $5,420,060 | SEC Form 4 |
| 2026-02-27 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | 1,084,010 | $5.00 | $5,420,050 | SEC Form 4 |
| 2026-02-27 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | 831,978 | $5.00 | $4,159,890 | SEC Form 4 |
| 2026-02-27 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | 2,000,000 | $5.00 | $10,000,000 | SEC Form 4 |
| 2026-02-27 | Hamilton Thomas Edward | director | 100,000 | $5.00 | $500,000 | SEC Form 4 |
| 2026-02-27 | THOMAS FRANK E | director | 5,000 | $5.00 | $25,000 | SEC Form 4 |
| 2026-02-27 | SHERMAN JEFFREY W | director | 5,000 | $5.00 | $25,000 | SEC Form 4 |
Last updated July 13, 2026.
ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.